16 Baillie Gifford Recursion Pharmaceuticals Trades
Baillie Gifford's position in Recursion Pharmaceuticals is currently worth $107 Million. That's 0.09% of their equity portfolio (117th largest holding). The investor owns 4.76% of the outstanding Recursion Pharmaceuticals stock. The first Recursion Pharmaceuticals trade was made in Q2 2021. Since then Baillie Gifford bought shares five more times and sold shares on ten occasions. The investor's estimated purchase price is $611 Million, resulting in a loss of 82%.
Avg closing price
Price range
Sold 1.9% shares (-471 Thousand shares)
Q1 2025
Avg closing price
$7.33
Price range
$5.29
-
$10.87
Sold 1.5% shares (-376 Thousand shares)
Q4 2024
Avg closing price
$6.72
Price range
$5.70
-
$8.27
Sold 5.1% shares (-1.35 Million shares)
Q3 2024
Avg closing price
$7.17
Price range
$5.92
-
$8.60
Increased shares by 10.5% (+2.52 Million shares)
Q2 2024
Avg closing price
$8.72
Price range
$7.35
-
$10.05
Sold 0.5% shares (-112 Thousand shares)
Q1 2024
Avg closing price
$11.14
Price range
$9.13
-
$15.52
Sold 1.5% shares (-372 Thousand shares)
Q4 2023
Avg closing price
$7.13
Price range
$5.09
-
$10.79
Sold 2.2% shares (-546 Thousand shares)
Q3 2023
Avg closing price
$9.98
Price range
$6.59
-
$15.86
Sold 0.2% shares (-37.9 Thousand shares)
Q2 2023
Avg closing price
$7.00
Price range
$4.56
-
$9.94
Increased shares by 1.3% (+315 Thousand shares)
Q1 2023
Avg closing price
$7.93
Price range
$6.42
-
$9.64
Increased shares by 14.9% (+3.23 Million shares)
Q4 2022
Avg closing price
$9.81
Price range
$7.16
-
$12.70
Sold 0.1% shares (-11 Thousand shares)
Q3 2022
Avg closing price
$10.13
Price range
$7.83
-
$13.60
Sold 1.7% shares (-376 Thousand shares)
Q2 2022
Avg closing price
$6.69
Price range
$5.04
-
$9.26
Sold 0.6% shares (-142 Thousand shares)
Q1 2022
Avg closing price
$10.63
Price range
$6.16
-
$18.03
Increased shares by 0.3% (+61.8 Thousand shares)
Q4 2021
Avg closing price
$18.82
Price range
$16.14
-
$21.86
Increased shares by 19.1% (+3.54 Million shares)
Q3 2021
Avg closing price
$28.34
Price range
$19.03
-
$41.33
New holding (+18.5 Million shares)
Q2 2021
Avg closing price
$29.60
Price range
$21.06
-
$37.42
